HOME › Press Releases › RNA Analysis/ Transcriptomics Market worth $3,773.0 Million by 2019
RNA Analysis/ Transcriptomics Market worth $3,773.0 Million by 2019
The report "RNA Analysis/Transcriptomics Market by Technology (Microarray, PCR, NGS, RNAi), by Application (Clinical Diagnostics, Drug Discovery, Toxicogenomics), by End-User (Academic Research, Pharmaceutical and Biotech Companies) - Global Forecast to 2019" The global transcriptomics market is estimated to be worth $1985.5 million by the end of 2014 and is expected to reach $3,773.0 million by 2019, at a CAGR of 13.7% from 2014 to 2019.
Browse 217 market data tables with 20 figures spread through 300 pages and in-depth TOC on "RNA Analysis/Transcriptomics Market by Technology (Microarray, PCR, NGS, RNAi), by Application (Clinical Diagnostics, Drug Discovery, Toxicogenomics), by End-User (Academic Research, Pharmaceutical and Biotech Companies) - Global Forecast to 2019"
Early buyers will receive 10% customization on reports.
This report studies the transcriptomics market over the forecast period of 2014 to 2019.
There is increasing demand for personalized medicines and continuous improvements in healthcare infrastructures which drives the growth of drug discovery and research. This has given a thrust to the demand for transcriptomic technologies which are widely used for the drug discovery and life science research. Moreover, the increasing number of pharmaceutical and biotechnology companies in Asia-Pacific region has opened new growth avenues for transcriptomics in the emerging markets. However, the higher initial investment cost hampers the growth of this market due to the reluctance of researchers to adopt the new technologies. Moreover, the dearth of skilled professionals and efficient bioinformatics tools for data analysis can inhibit the growth of transcriptomics market to a certain extent.
In this report, the market is segmented on the basis of different types of technologies, applications, end-users, and geographies. This report also discusses the key market drivers, restraints, opportunities, and challenges. The global market is estimated to be worth $1985.5 million by the end of 2014 and is expected to reach $3,773.0 million by 2019, at a CAGR of 13.7% from 2014 to 2019.
In 2013, North America region holds the major share in the global transcriptomics market, followed by Europe and Asia-Pacific..The major share of the North American region is primarily attributed to the presence and expansion of major pharmaceutical and biotechnology companies in this region, especially in the U.S. Similarly, the increasing adoption of transcriptomics in drug discovery and clinical diagnostics has driven the growth of North American transcriptomics market. On the other hand, with the increasing number of biotechnology companies in Asia-Pacific region and thereby the rising research and development activities, the transcriptomics market in Asia-Pacific region is expected to grow at the highest rate during the forecast period.
The prominent players in the market are Affymetrix Inc. (U.S.), Agilent Technologies Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), GE Healthcare (U.S.), Illumina Inc. (U.S.), Qiagen N.V. (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Sigma Aldrich (U.S.), Fluidigm Corporation (U.S.), and Thermofisher Scientific Inc. (U.S.).
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
North - Dominion Plaza,
Suite 800, Dallas, TX 75252